Skip to Main Content

"Keeping Time in the Clinic - Understanding and Managing the Circadian Patient" Sabra Abbott (04/13/2022)

April 20, 2022

"Keeping Time in the Clinic - Understanding and Managing the Circadian Patient" Sabra Abbott (04/13/2022)

 .
  • 00:00My name is Andrea Zentrack and I'm
  • 00:03an assistant professor at Yale
  • 00:05University School of Medicine.
  • 00:07And welcome to yet another edition of
  • 00:10the Joint Sleep Conference between
  • 00:14our programs in the Northeast.
  • 00:15I think we've grown from 2.
  • 00:18Two programs to 6. And I don't know.
  • 00:22Just say that we have an
  • 00:24outstanding speaker today,
  • 00:26and so during the talk I'll ask
  • 00:28you that you mute yourselves.
  • 00:30If you have a question or
  • 00:32wanted to make him comment,
  • 00:34please do so in the chat.
  • 00:37In the chat is where also
  • 00:40instructions for obtaining CME
  • 00:42credit for today's talk will appear.
  • 00:45And so if you are not
  • 00:47registered with the LCM,
  • 00:48you would have to do that first.
  • 00:50And you can receive credit for
  • 00:53attending the session 15 minutes
  • 00:55prior to the end or 15 minutes
  • 00:57after the end of the session.
  • 01:01And so, without further ado,
  • 01:03I wanted to introduce the
  • 01:05very special speaker today.
  • 01:08A friend of mine and a colleague
  • 01:11of mine doctor Sabera Abbott,
  • 01:13and so Doctor Abbott is an
  • 01:16assistant professor of neurology
  • 01:18at the Northwestern Medicine.
  • 01:20And in Chicago, and I know Sabra,
  • 01:23since our residency times and neurology
  • 01:26back in Beth Israel Deaconess when
  • 01:29I did my detour through neurology
  • 01:30before I went to a pulmonary critical
  • 01:32care and then eventually sleep,
  • 01:33and so little,
  • 01:34did we know we started in the same
  • 01:36place and ended up in the same domain?
  • 01:38And so I'm really excited to have
  • 01:41her talk to us today because
  • 01:43she is an outstanding physician,
  • 01:46incredible scientist,
  • 01:46and the and a a great clinician
  • 01:50who cares about her patients.
  • 01:52But aside from that,
  • 01:54she started her academic career
  • 01:56at Carleton College,
  • 01:58where she received the BA in Psychology
  • 02:01and then moved on to University
  • 02:02of Illinois at Urbana Champaign,
  • 02:04where she got her masters,
  • 02:06followed by a PhD in Molecular
  • 02:08and integrative Physiology,
  • 02:10and then got her MD there before
  • 02:12moving on to Beth Israel Deaconess
  • 02:14Medical Center with Harvard,
  • 02:16where she got her.
  • 02:18Neurology residency,
  • 02:19where she was also a chief resident,
  • 02:21and.
  • 02:22Completed her clinical sleep fellowship
  • 02:25back in Chicago at Northwestern and
  • 02:29so Sabra is a prolific academician.
  • 02:35She does research and has ROI and
  • 02:38program grants that she is a Co
  • 02:41investigator on and she's old so
  • 02:45published dozens of papers and.
  • 02:49Chapters that are read throughout the
  • 02:53world and are also appear in doctor
  • 02:58Kriegers principles and practice,
  • 03:00Sleep Medicine,
  • 03:01and so just looking at her first publication,
  • 03:04it sort of gives it away of
  • 03:06what her passion is and her
  • 03:08first publication back in 2003,
  • 03:10and journal Neuroscience is
  • 03:11circadian clock controlled
  • 03:12regulation of cyclic GMP protein
  • 03:14kinase G in an external domain,
  • 03:16and so she is a.
  • 03:21Aficionado of circadian clock.
  • 03:23And that's what she's going to talk to us
  • 03:26today about keeping time in the clinic.
  • 03:28Understanding and managing the
  • 03:30circadian patient from bedside
  • 03:32to from bench to bedside. And so.
  • 03:35I'm looking forward to the stock.
  • 03:37Thank you so much for being with
  • 03:39us Zebra and let's get to it.
  • 03:42Great, well thank you Andre for
  • 03:44that very very kind introduction
  • 03:46and I too am very pleased that
  • 03:49despite losing you as a neurologist,
  • 03:51our paths continued across along the way so.
  • 03:56It was in one of our discussions that
  • 03:58Andre and I actually had about this
  • 03:59talk where he made what I thought
  • 04:01was a very insightful comment.
  • 04:03Which and I don't know if you
  • 04:04even remember this,
  • 04:04but you said that circadian rhythms are
  • 04:07like the neurology of Sleep Medicine,
  • 04:09and I think that is very true
  • 04:11in some respects.
  • 04:12I think that circadian rhythms and
  • 04:14neurology are both a little intimidating.
  • 04:16When you first experience
  • 04:18them and 1st approach them.
  • 04:19But once you actually understand
  • 04:21the logic behind them,
  • 04:22they can be incredibly gratifying.
  • 04:24And really a great field to be in.
  • 04:27Granted,
  • 04:27I have the bias that I am a neurologist
  • 04:30who specializes in circadian rhythms,
  • 04:32so maybe I am taking that
  • 04:34a little personally,
  • 04:34but my overall goal today is
  • 04:36really to try to make circadian
  • 04:38biology a little less intimidating
  • 04:40for everybody in the audience,
  • 04:42and I know we've got a wide range
  • 04:44of experience just based on some of
  • 04:46the names that I've seen coming in
  • 04:47in terms of how comfortable people
  • 04:49may be with circadian biology,
  • 04:51but hopefully everybody will
  • 04:52walk away just feeling a little
  • 04:54bit better about the topic.
  • 04:56I'm gonna start off.
  • 04:57With just a general overview
  • 04:59of circadian rhythms,
  • 05:01just to make sure everybody is
  • 05:02starting off on the same page and
  • 05:04then gonna walk through a couple of
  • 05:05case examples of patients who've
  • 05:07come through the circadian clinic
  • 05:08with me both going through them as an
  • 05:11illustration of sort of how to manage
  • 05:13the bread and butter circadian patient,
  • 05:15but also some tips and tricks that
  • 05:17we've taken from the research
  • 05:18domain to try to help manage them.
  • 05:20And then lastly,
  • 05:21I'll wrap up with a summary of
  • 05:23a research project we recently
  • 05:26completed that was really based on.
  • 05:28Some of the insights that we
  • 05:29had from seeing these patients.
  • 05:31So without further ado.
  • 05:34First step is to get the slides to advance.
  • 05:36There we go, so I have no disclosures.
  • 05:39And as Andre said,
  • 05:40the CME information is also gonna
  • 05:42be in the chat for you,
  • 05:43but it's on the screen here.
  • 05:46So just to get things started,
  • 05:47I always want to make sure that we
  • 05:49kind of talk through the general
  • 05:51concept of what do we even mean
  • 05:53when we're talking about circadian
  • 05:54rhythms and they're in general all
  • 05:56of the physiological processes that
  • 05:59we have that have a near 24 hour
  • 06:02or about a day property to them.
  • 06:05And I think it's easiest to understand
  • 06:07these if we think about them from
  • 06:09the idea of our sleep wake rhythms,
  • 06:12because those definitely have a daily
  • 06:14occurrence to them, and so I've.
  • 06:17Plotted out here just a very idealized
  • 06:20sleep wake schedule of somebody,
  • 06:22and so we've got daytime over here.
  • 06:23On the left.
  • 06:24We've got night time here,
  • 06:26and these black bars are the sleep
  • 06:27periods for each of these individuals,
  • 06:29or for this one individual.
  • 06:31And you can see that in this 24 hour
  • 06:34environment every day they go to bed at
  • 06:35the same time wake up at the same time,
  • 06:37and they're generally sleeping when
  • 06:39it's dark out, but the question?
  • 06:41The first one that comes up is,
  • 06:43is this something that is simply
  • 06:45a response to the environment?
  • 06:47So the sun goes down.
  • 06:48So we decide maybe we'll go to sleep.
  • 06:50The sun comes up, we wake up.
  • 06:51Or is this something that's
  • 06:53actually intrinsic to your biology?
  • 06:55Is this something that would
  • 06:57happen even outside of that?
  • 06:59Twenty that light,
  • 07:01dark environment,
  • 07:02and so several researchers set out
  • 07:04to try to answer this question.
  • 07:06One of them was the pair of
  • 07:08Nathaniel Kleitman and his
  • 07:10graduate student Bruce Richardson.
  • 07:12And they did an experiment where
  • 07:14they went into Mammoth Cave in
  • 07:15Kentucky and monitored their sleep.
  • 07:17Behaviors in the absence of
  • 07:19those light dark time cues,
  • 07:22and then similarly,
  • 07:23you're going to ask off who is
  • 07:25really considered kind of the
  • 07:27father of human circadian biology,
  • 07:29underwent a series of bunker experiments
  • 07:31in Germany where he took subjects
  • 07:33and put them into this bunker here
  • 07:36and then monitored their behavior in
  • 07:38the absence of those external time cues,
  • 07:41I encourage you to go read
  • 07:42these original papers,
  • 07:44but I just took a small excerpt from
  • 07:46them here and you can see he describes.
  • 07:48There's a locked double door at the entrance
  • 07:50in the small room between the two doors.
  • 07:53An ice box serves for a first storage of
  • 07:55urine samples through the same channel.
  • 07:58We supply the subject with fresh
  • 08:00food and other necessities such
  • 08:01as one bottle of endex beer daily.
  • 08:03So remember that when you're
  • 08:05writing your Irbs include beer.
  • 08:07If you're doing German research studies,
  • 08:10but what I thought was really
  • 08:12insightful about this was that
  • 08:13he also participated in his own
  • 08:15studies as a research participant,
  • 08:17and so this is actually a plot of his own.
  • 08:20Sleep wake rhythms when he was in
  • 08:23that bunker and so you can see these
  • 08:25black lines here are when he was
  • 08:27going to bed and waking up each night
  • 08:29as well as plotting the rhythms of
  • 08:31his urine output during that time.
  • 08:35He included in the paper this
  • 08:37comment that from the knowledge
  • 08:39of animal experiments,
  • 08:41I was convinced that I had a
  • 08:43period shorter than 24 hours,
  • 08:44which had previously been seen
  • 08:47in many nocturnal animals,
  • 08:49such as mice for example.
  • 08:51But he said when I was released on day 10,
  • 08:53I was therefore highly surprised to be
  • 08:55told that my last waking up time was 3:00 PM,
  • 08:57and so again an example that even the
  • 08:59best minds in the world sometimes are
  • 09:01hypothesis are wrong and we have to
  • 09:03sort of change our thinking about things.
  • 09:05But I think also just a very interesting,
  • 09:07interesting description of these first
  • 09:10experiments trying to figure out
  • 09:12what actually happens to humans
  • 09:14in the absence of these time cues.
  • 09:16So as you can see here,
  • 09:17if we took our idealized human here,
  • 09:20put them in an environment
  • 09:22devoid of time cues each day,
  • 09:24most humans get a little bit later
  • 09:27and a little bit later each day.
  • 09:30These behaviors are primarily regulated
  • 09:32by the Super cosmetic nucleus,
  • 09:34and so I have a cross section here.
  • 09:36This is a coronal section through a human
  • 09:40hypothalamus and you can see basically here.
  • 09:42We've got our optic chiasm,
  • 09:44the Super chiasmatic nucleus are these
  • 09:46two little areas outlined in yellow here.
  • 09:48They're directly above the optic
  • 09:50chiasm and within the hypothalamus,
  • 09:52so they can receive light
  • 09:54information from the environment,
  • 09:55and then they can also take that information
  • 09:58and send signals to the hypothalamus.
  • 10:00Where they can regulate things like sleep,
  • 10:02wake behavior, feeding behavior,
  • 10:04core body temperature,
  • 10:06rhythmic hormone release,
  • 10:07everything else that has
  • 10:08that daily rhythm to it.
  • 10:10Now we know that it's not just the SCN it
  • 10:13seems to be sort of the primary pacemaker,
  • 10:16but every other cell and tissue
  • 10:18in our body also has a clock in
  • 10:20it and the SCN we think serves
  • 10:22to help coordinate and keep those
  • 10:24clocks In Sync with each other.
  • 10:27So I think one of the things that I
  • 10:29find most fascinating about circadian
  • 10:31biology is not only that we have this
  • 10:34intrinsic time keeping mechanism,
  • 10:36but it's also dynamic and it can be reset
  • 10:40like a clock or a watch with time cues,
  • 10:44and that resetting is both stimulus
  • 10:47specific and time of day specific.
  • 10:50So if we go back to our human example,
  • 10:52so now we've put them in a cave,
  • 10:54they have no light, dark exposure.
  • 10:56Each day, they're going to bed.
  • 10:57A little bit later and a little bit later,
  • 10:59and if we come in at some point
  • 11:02during their biological daytime,
  • 11:04the time when they'd normally be
  • 11:06awake normally be expecting to see
  • 11:08light and expose them to light.
  • 11:09You can see that the following day,
  • 11:11it really doesn't change that daily rhythm,
  • 11:14but if instead we came in shortly
  • 11:17after the time that they fell asleep,
  • 11:19so during a time when they normally
  • 11:21wouldn't expect to be seen light
  • 11:23and expose them to light,
  • 11:24you can see that the following day
  • 11:26that whole behavior gets later.
  • 11:28And you can interpret that as
  • 11:30almost an error signal.
  • 11:32So perhaps the signal that day
  • 11:34length is longer than expected,
  • 11:37so we should push everything later.
  • 11:38So again,
  • 11:39we're sleeping when it's dark
  • 11:41and we're awakening it's light.
  • 11:42And then on the other end of the spectrum,
  • 11:44if you take them and expose them
  • 11:46to light in the early morning.
  • 11:48So shortly before they were gonna wake
  • 11:50up shortly before dawn would normally occur,
  • 11:53you can see that the following
  • 11:54day they actually get earlier,
  • 11:55and so again a stimulus that daylight
  • 11:58is showing up earlier than expected.
  • 12:00We should move everything earlier,
  • 12:01so again, we're appropriately aligned.
  • 12:05In order to actually plot these results,
  • 12:07we use something called a
  • 12:08phase response curve and we'll
  • 12:10show some more of these later.
  • 12:11But basically this is just a 24
  • 12:15hour plot here and our stimulus
  • 12:18during the daytime has no effect,
  • 12:20so it's not causing a phase shift,
  • 12:22whereas our early evening
  • 12:23stimulus is causing a delay
  • 12:25or a negative deflection here,
  • 12:27and our stimulus at the end of
  • 12:29the night is causing an advance
  • 12:30or a positive deflection here.
  • 12:32Now that was a cartoon.
  • 12:33This is what it actually looks
  • 12:34like in real life.
  • 12:35This is an example of a light phase
  • 12:38response curve obtained from humans
  • 12:39and one of the important things to
  • 12:42keep in mind when you're managing
  • 12:44circadian patients is the switch point,
  • 12:46right here,
  • 12:47and so we know that this occurs
  • 12:49about the point of the core
  • 12:52body temperature nature,
  • 12:53which for most people occurs about 2
  • 12:55hours before their natural wait time.
  • 12:57So if you're trying to time light
  • 12:59to appropriately shift a patient
  • 13:01in One Direction or another,
  • 13:03it's really important that your
  • 13:04timing that light based on their.
  • 13:06Biological time and not based
  • 13:08on the external clock time just
  • 13:10to give you an example,
  • 13:11many of my patients don't fall asleep
  • 13:14till 345 in the morning and so if I
  • 13:15were to give them light in the quote,
  • 13:17UN quote morning,
  • 13:18so at 7:00 or 8:00 AM,
  • 13:20I'd actually still be hitting
  • 13:21them on the spades delay portion
  • 13:23of the phase response curve and
  • 13:25could potentially make them even
  • 13:26worse by shifting them later.
  • 13:28So making sure that you keep this in
  • 13:30mind when you're trying to determine
  • 13:33treatment timing for your patients.
  • 13:35Now one of the other.
  • 13:38Stimuli that we make use of in the clinic.
  • 13:40Like I mentioned,
  • 13:41each response is both time of
  • 13:44day and stimulus dependent,
  • 13:46and so one of the other tools
  • 13:47we use is melatonin,
  • 13:49so our bodies naturally produce melatonin,
  • 13:52typically with levels rising a few hours
  • 13:55before you naturally fall asleep at night.
  • 13:57As you can see,
  • 13:58indicated by the up arrow here
  • 14:00and then dropping off as we fall
  • 14:01asleep and the proposed sleep
  • 14:03window is approximately here.
  • 14:05With these, these upright lines here.
  • 14:08And so with melatonin.
  • 14:10Again, think of it like an error signal.
  • 14:12So if you give someone melatonin before
  • 14:15they would naturally be producing it,
  • 14:18you end up pulling them
  • 14:20earlier or advancing them.
  • 14:21Whereas if you give them melatonin
  • 14:23after they stop producing it,
  • 14:25you end up delaying them
  • 14:26or pulling them later.
  • 14:27And so again,
  • 14:28tools that we can make use of in the
  • 14:31clinic to try to help shift people
  • 14:33in One Direction or the other.
  • 14:35But keeping in mind that if
  • 14:37you give somebody melatonin.
  • 14:38You want to make sure that if
  • 14:40you're giving them melatonin
  • 14:41with the goal of advancing them,
  • 14:43you wanna make sure that you're
  • 14:46having the melatonin present here,
  • 14:47but no longer having it present here,
  • 14:50which is why we care so much
  • 14:52about dosing of
  • 14:53melatonin, because we want to make
  • 14:55sure we don't give them a really
  • 14:56high dose of melatonin here,
  • 14:58so it may help advance.
  • 15:00But then it's still sitting
  • 15:01around in the system out here,
  • 15:03where then it's delaying and
  • 15:05then working against us.
  • 15:10So with that as the introduction,
  • 15:13I now want to move on to talking
  • 15:15about how we actually put this
  • 15:17into practice in the clinic,
  • 15:19and we think of primarily these four main
  • 15:22intrinsic circadian rhythm sleep disorders,
  • 15:24advanced delayed non 24 in your
  • 15:27regular sleep wake rhythm disorder.
  • 15:29We also do see some shift work disorder.
  • 15:33Excuse me and then very rarely some jet lag.
  • 15:37Starting to come back now,
  • 15:38but had a two year hiatus from that.
  • 15:40With the Payam pandemic certainly,
  • 15:43but for today what I really wanna
  • 15:45focus on are the two disorders
  • 15:46I tend to see most in clinic.
  • 15:48Specifically, delayed sleep,
  • 15:50wake phase disorder and non 24 and
  • 15:53we're going to start off with the case.
  • 15:58So we have a patient who is a 34 year old
  • 16:01woman and she comes into clinic and says,
  • 16:04you know I used to be a quote
  • 16:05UN quote normal sleeper.
  • 16:06I'd go to bed around 11.
  • 16:08I'd have no trouble falling asleep
  • 16:10sleep through the night. I was fine.
  • 16:12She got into a car accident,
  • 16:14had a whiplash injury.
  • 16:15And really since that point,
  • 16:17her bedtime moved around to the point
  • 16:19where by the time she came to see me,
  • 16:22she was often not falling asleep till 3:30.
  • 16:24Sometimes as late as nine.
  • 16:25AM. And so as a first step,
  • 16:28when evaluating these patients really
  • 16:29what we want to do is get a sense of
  • 16:32what are their patterns really like,
  • 16:34and to do that,
  • 16:35we use something called actigraphy.
  • 16:37So this is just an example of one of
  • 16:39the actigraphy watches we use in clinic,
  • 16:42and an example of what the
  • 16:43data might look like.
  • 16:44This is not from this patient,
  • 16:45as you'll quickly figure out,
  • 16:48but basically general activity.
  • 16:50Again, we plot in 24 hours,
  • 16:52so we're going from noon to noon.
  • 16:54Activity is indicated by
  • 16:56these black bars here.
  • 16:58Light exposure by the yellow
  • 17:00line that's running through
  • 17:01here and then we've highlighted
  • 17:03the sleep window here in blue,
  • 17:05and so this is actually for myself.
  • 17:07When I was testing.
  • 17:08One of these watches,
  • 17:09and you'll see why I didn't use
  • 17:11the patient as an example here,
  • 17:13because it gets much messier
  • 17:15in the clinical environment.
  • 17:17And so these dark blue bars here are
  • 17:20actually when the patient took the watch off.
  • 17:23So you can see the first problem is
  • 17:26simply getting patients to wear the
  • 17:27watch for the full one to two or three
  • 17:30weeks that you're having them wear them.
  • 17:32But the other thing is that you can
  • 17:34see from this recording are one.
  • 17:36The overall activity thresholds
  • 17:37were sent the set the same on
  • 17:39both of those actor grams,
  • 17:41but you can see this patient
  • 17:43is quite inactive overall.
  • 17:44And then you can also see overall
  • 17:46her sleep patterns are quite
  • 17:48irregular in terms of wait time.
  • 17:50Often this is set by other obligations,
  • 17:53for example like having to
  • 17:54get to work on time,
  • 17:55but on average she's typically
  • 17:57falling asleep somewhere on one to
  • 17:59two in the morning during this time
  • 18:01frame and getting up anywhere from
  • 18:048 to noon depending on the day.
  • 18:07So one of the other tools that we
  • 18:09can make use of to try to get a
  • 18:11sense of whether a patient has a
  • 18:13circadian disorder and what exactly it is,
  • 18:15is to get a sense of what time
  • 18:17they're naturally producing.
  • 18:19Melatonin.
  • 18:19Like I said,
  • 18:20for most people that typically starts
  • 18:22an hour or about two to three hours
  • 18:24before their natural sleep time.
  • 18:26And so in clinic we've set up these
  • 18:29kits where we can actually collect
  • 18:31melatonin from an individual saliva.
  • 18:33So over here we've got these tubes.
  • 18:35They have a little cotton swabs in them.
  • 18:37They can go through these in
  • 18:39order every half hour to hour.
  • 18:41During that time point before bedtime,
  • 18:43we have them wear these blue blocking
  • 18:45glasses and dim the lights during
  • 18:47that time and using that we can
  • 18:49then obtain a profile of what their
  • 18:51normal melatonin profiles look like.
  • 18:53So in this particular patient you
  • 18:55can see her saliva melatonin here,
  • 18:58so she started collecting around
  • 18:597:30 and you can see that the point
  • 19:02at which your melatonin started
  • 19:04to rise is just after midnight,
  • 19:06and so this fits with her report when
  • 19:08she came in of often not falling
  • 19:10asleep till 2-3 in the morning,
  • 19:12and so all of this data together.
  • 19:15Really supports the diagnosis of delayed
  • 19:18sleep wake phase disorder and I've
  • 19:21included here the ICCSD 3 criteria.
  • 19:23Basically,
  • 19:24you need a significant delay in the
  • 19:25phase of the major sleep episode in
  • 19:27relation to the desired or required
  • 19:29sleep time and wake up time.
  • 19:31Symptoms have to be present for
  • 19:32at least three months,
  • 19:33but if they're allowed to
  • 19:35choose their own schedule,
  • 19:36they actually sleep better.
  • 19:39It look like to diagnose this with either
  • 19:42a sleep log or actigraphy for at least 7,
  • 19:45preferably 14 days.
  • 19:46To show this delay in the
  • 19:48timing of their sleep period,
  • 19:49and then obviously you want
  • 19:51to make sure that you rule out
  • 19:54other sleep disorders that could
  • 19:56be explaining this better.
  • 19:57In terms of what causes delayed
  • 19:59sleep wake phase disorder,
  • 20:00there are many potential theories,
  • 20:02so there are familial cases of this,
  • 20:05and so there's been a description
  • 20:07of a cryptochrome 1 mutation
  • 20:09in some families with this.
  • 20:10This is one of the core clock genes,
  • 20:12and I didn't go into this
  • 20:14in the introduction,
  • 20:14but we have within each of ourselves
  • 20:17a core set of clock genes and that
  • 20:21transcription translation feedback loop
  • 20:23typically takes about 24 hours to complete,
  • 20:26but mutations?
  • 20:27Could be their speed that up or slow
  • 20:29that down can either make you advanced
  • 20:31in the case of speeding it up or
  • 20:34delay in the case of slowing it down.
  • 20:36So you can think of these patients
  • 20:38as simply just persistently running
  • 20:40a little bit behind everybody else.
  • 20:43And that goes along with demonstrations
  • 20:45from several labs that these patients
  • 20:47tend to have a longer circadian period.
  • 20:50So left to their own devices they
  • 20:52get later and later each day much
  • 20:55later than the average person.
  • 20:57And there have been several reported
  • 20:58cases of people with head injuries,
  • 21:00and we think that this may be due to
  • 21:03either a delay and or decrease in the
  • 21:05amplitude of melatonin production.
  • 21:07And then we'll get into this a
  • 21:09little bit more later,
  • 21:10but there does also seem to be a role
  • 21:12for both timing of exposure as well
  • 21:14as responsiveness to bright light.
  • 21:18So we've made the diagnosis.
  • 21:20Now what do we do as far
  • 21:22as treating this patient?
  • 21:24And I've put up two things.
  • 21:26We'll get to the next one,
  • 21:27so I've included here.
  • 21:29The current published 2015
  • 21:31ASM treatment guidelines,
  • 21:33which basically say that in
  • 21:34both adults and children,
  • 21:36we recommend using
  • 21:38strategically timed melatonin.
  • 21:40Now I will say that I don't actually
  • 21:42follow what's currently in the guidelines,
  • 21:44so the one reference that they cite
  • 21:47actually was a study that used 5
  • 21:50milligrams between 7:00 and 9:00 PM.
  • 21:52And So what I've put here is actually
  • 21:54what I tend to do clinically,
  • 21:56and we're starting to work together
  • 21:57with several other circadian clinics
  • 21:59on some consensus guidelines.
  • 22:00And I think we're all in agreement
  • 22:03that we typically now tend to go lower
  • 22:05and have changed the timing slightly.
  • 22:07So if I'm managing a patient with
  • 22:10delayed sleep wake phase disorder.
  • 22:12I will typically give them
  • 22:13half a milligram of melatonin.
  • 22:15Again,
  • 22:15with that idea of keeping that
  • 22:17dose low so it's that strategic
  • 22:19pulse that's there when you
  • 22:21need it and gone when you don't.
  • 22:23And based on that phase response
  • 22:24curve that I showed you earlier,
  • 22:26it's about five hours prior
  • 22:27to their current bedtime,
  • 22:29so if they biologically were allowed
  • 22:31to sleep when they prefer to,
  • 22:34or if they're not that delayed,
  • 22:36we're just trying to shift
  • 22:37them an hour or two.
  • 22:38I will sometimes just give it an
  • 22:40hour prior to their desired bedtime,
  • 22:42and we'll go through some of that.
  • 22:43Data for that in the next slide.
  • 22:46It's key for all of these patients to
  • 22:48avoid bright light prior to bedtime,
  • 22:50we'll talk about some of the
  • 22:52data supporting that later.
  • 22:53And then we also make sure that they
  • 22:56get bright light after their wake
  • 22:58time and that can be anywhere from 30
  • 23:00minutes to two hours of light total.
  • 23:02I usually spread that out over
  • 23:044 hours and again,
  • 23:05like I emphasized if they're having to
  • 23:07get up earlier than they naturally would,
  • 23:10I actually have them wear dark
  • 23:11glasses until that time when they
  • 23:13would be waking up so they're not
  • 23:15inadvertently getting bright light
  • 23:16during the phase delay portion of the
  • 23:18phase response curve instead of the
  • 23:20phase advanced portion where we want it.
  • 23:23So I told you I'd go through the rationale
  • 23:26for the one hour prior to desired bedtime.
  • 23:28So after the ASM guidelines came
  • 23:30out this this study was published,
  • 23:32which basically was looking at the
  • 23:35use of melatonin in the treatment of
  • 23:38delayed sleep wake phase disorder.
  • 23:39They took 116 participants with
  • 23:42delayed sleep wake phase disorder.
  • 23:44They define that as the delmo had to either
  • 23:46occur less than 30 minutes before or at
  • 23:48some point after their desired bedtime.
  • 23:51So there was a mismatch
  • 23:52between their biological.
  • 23:54Timing and when they wanted to sleep.
  • 23:57In, on average, these patients
  • 23:59had a sleep onset of about 1:30.
  • 24:02Their sleep offset was at about 9:00 AM.
  • 24:05And they were randomized to either
  • 24:07four weeks of placebo or half
  • 24:09a milligram of melatonin,
  • 24:10and they were told to take it one
  • 24:12hour prior to their desired bedtime
  • 24:14and then to get into bed at that
  • 24:16desired bedtime and on average for
  • 24:17the study population they wanted
  • 24:19to go to bed at about 10:30.
  • 24:23After that four weeks,
  • 24:24they found that the melatonin group
  • 24:26had an onset sleep onset time that
  • 24:28moved about half an hour earlier.
  • 24:29Their sleep efficiency also improved.
  • 24:31They did do a subgroup analysis
  • 24:33where they didn't actually find
  • 24:35a significant change in Dino,
  • 24:37and to go back to the point
  • 24:39that I made earlier that I do
  • 24:41differentiate between the milder and
  • 24:43the more severe delayed patients.
  • 24:46This tends to work pretty well,
  • 24:47for example, if it's a patient
  • 24:50who's falling asleep at 12:31.
  • 24:52They wanna fall asleep at 1111 thirty.
  • 24:55It tends to help them shift at that point,
  • 24:57and they're not spending a tremendous
  • 25:00amount of time in bed not able to sleep.
  • 25:03But take for example if I have one of
  • 25:05my patients who doesn't fall asleep
  • 25:07till 3-4 or five in the morning,
  • 25:09but they'd like to fall asleep at 11.
  • 25:12Now I'm telling them take this
  • 25:14melatonin at 10:00 PM. Get into bed 11.
  • 25:17And lay there for five hours.
  • 25:20Obviously that's just going to feed
  • 25:22into some of their frustrations
  • 25:24that they've been dealing with for
  • 25:26most of their life, and we do see.
  • 25:29A lot of comorbid insomnia in these patients,
  • 25:32and so that's why if we're trying
  • 25:34to make larger moves,
  • 25:35there's a larger mismatch.
  • 25:36We tend to do this more targeted
  • 25:38treatment where we really inch
  • 25:40their rhythm earlier instead.
  • 25:44So going back to case one so we treated
  • 25:46her with that timed melatonin timed light.
  • 25:48She responded really well and
  • 25:50she actually was able to shift
  • 25:52her bedtime to about 10:00 PM.
  • 25:53Her sleep latency decreased about 10 minutes,
  • 25:56which was great and she actually
  • 25:58did really well for about two years.
  • 26:00But then she started having several
  • 26:02days per week where she started drifting
  • 26:04later so she was falling asleep and
  • 26:07waking up later and ended up having to
  • 26:09miss or be late to several days of work.
  • 26:11She was at the point where she was about to.
  • 26:13Trust or sick days.
  • 26:14She was potentially gonna lose
  • 26:16her job and so we really needed to
  • 26:18figure out something to do.
  • 26:20And it was actually right around this
  • 26:22time that Ken writes group published
  • 26:24this study and so another one.
  • 26:26If you haven't read it,
  • 26:27definitely take a look at this,
  • 26:28but this was his infamous camping study
  • 26:31where he took a group of individuals
  • 26:33and you could see indicated over here
  • 26:36under electrical lighting conditions.
  • 26:38Their melatonin onset was
  • 26:40occurring sometime after sunset.
  • 26:42They're offset was occurring.
  • 26:43After sunrise,
  • 26:44so they were delayed with
  • 26:46respect to the environment.
  • 26:48He took them camping in Colorado
  • 26:50for a week and with that natural
  • 26:53light exposure he managed to shift
  • 26:55everybody earlier and better in,
  • 26:57train them with the environment.
  • 26:59You can see melatonin onset and
  • 27:02offset are now better matched with
  • 27:04sunset and sunrise and so this
  • 27:07made it into the general public.
  • 27:10News had a lot of publicity
  • 27:12around it and so my patient.
  • 27:14All this and her question for me at
  • 27:16first was should I go to Colorado
  • 27:19and go camping and it turns out that
  • 27:22she is somebody who likes to camp.
  • 27:24She will often go camping in the
  • 27:26area in Illinois and Wisconsin
  • 27:27and we sort of talked through the
  • 27:29rationale behind the study.
  • 27:30And so there's really nothing magical
  • 27:32about the Rockies as far as we know.
  • 27:34It's really just that elimination of
  • 27:36electrical lighting that made the difference,
  • 27:39and so she actually was able to
  • 27:40set up a tent in her backyard.
  • 27:42This is not her tent,
  • 27:43it's a Google image of tent.
  • 27:45Backyard,
  • 27:46but she was able to set up a
  • 27:48tent in her backyard.
  • 27:50Really could follow that schedule for a week.
  • 27:52She turned off all electrical lights,
  • 27:54all lights in her yard.
  • 27:56The only thing that kind of failed
  • 27:58us along the way is one night a
  • 28:00skunk did come in sprayer tent,
  • 28:01but because we had talked
  • 28:03through what the principle was,
  • 28:04that one night she went into her house
  • 28:06trying to make sure she turned on.
  • 28:07No lights,
  • 28:08washed her tent the next day and
  • 28:10went back to it and it actually
  • 28:12worked really well.
  • 28:12So after a week of camping
  • 28:15we got our schedule.
  • 28:16Advanced and then she will sometimes
  • 28:18now go back and re entrain with these
  • 28:20electricity free weekends to kind
  • 28:21of get herself back on schedule.
  • 28:23And I think from a logistics
  • 28:25standpoint probably the thing I'm
  • 28:27most satisfied about is we could get.
  • 28:29We got her a week of short term
  • 28:31disability to do this camping as well.
  • 28:34So we got our employer to cover
  • 28:36it as part of her treatment.
  • 28:37So that was just a nice insight
  • 28:39into both how to manage the basic
  • 28:42circadian disorder as well as
  • 28:43how we make use of some of the
  • 28:46published data that's out there.
  • 28:47And now I'd like to move on to my
  • 28:50second case so this is another one of
  • 28:53my favorite patients who I've been
  • 28:55following pretty much from the bright after.
  • 28:58I think he may have been one of the first
  • 28:59patients I had as a brand new attending,
  • 29:01and I've been following him ever since.
  • 29:03At the time I first saw him,
  • 29:06he was 35.
  • 29:07He was somebody who like many of my patients,
  • 29:10said he's always been a night owl,
  • 29:12but he came in because at some point
  • 29:14things got worse and he could no
  • 29:16longer follow a 24 hour schedule
  • 29:18I've dubbed in the Martian because
  • 29:19a lot of my patients with this
  • 29:21disorder will refer to themselves
  • 29:23as that because the Mars day is a
  • 29:25little bit longer than the Earth Day.
  • 29:28So, like many of my patients,
  • 29:30he had kept meticulously blogs
  • 29:32before he came to see me,
  • 29:34and this is just an example of
  • 29:36what his sleep looked like before
  • 29:38things started to get even worse.
  • 29:41What I have here is a double plot,
  • 29:43and so we've got this sleep period.
  • 29:45Up here is replatted down here.
  • 29:47This is 48 hours and you'll see why
  • 29:49in the next slides it's a little
  • 29:51easier to plot things this way,
  • 29:52but if you wanted to just focus
  • 29:53on the right side to begin with.
  • 29:55What we have is kind of what we
  • 29:56typically see with these delayed.
  • 29:58Emotions that they sort of force
  • 30:00themselves into a midnight to 8:00 AM
  • 30:03scheduled during the week they delayed
  • 30:05to their preferred schedule on the weekend,
  • 30:07and then they go back and
  • 30:09forth and back and forth.
  • 30:10It's not great, but they can live with it.
  • 30:14He saw a very well meaning sleep
  • 30:17provider who was trying to treat
  • 30:18him initially by giving him some
  • 30:20bright light in the morning,
  • 30:22which you can see here and then he was
  • 30:25instructed to follow Chronotherapy.
  • 30:27So that idea of gradually delaying
  • 30:29your sleep wake period until you reach
  • 30:32the point where you're going to sleep
  • 30:34and waking up when you prefer to.
  • 30:36And at that point you're supposed
  • 30:38to try to put the brakes on it
  • 30:40and keep things from delaying.
  • 30:42And with that he was supposed
  • 30:44to start taking melatonin.
  • 30:45As indicated in green and using bright light.
  • 30:49Unfortunately,
  • 30:50he started drifting and just kept going,
  • 30:54and so by the time he came
  • 30:55to see me in the office,
  • 30:57this is what his actigraphy looked like,
  • 30:59and you can barely make out his activity.
  • 31:02He overall tends to be a fairly
  • 31:04inactive person, but if you kind
  • 31:06of lean back and squint a little,
  • 31:08you can see that his onset of activity
  • 31:10every day gets a little later and
  • 31:12a little later, and a little later.
  • 31:14This is an outlier here because
  • 31:15he had a doctor's appointment.
  • 31:17The other thing that's noteworthy about him,
  • 31:19and we'll get to this later.
  • 31:21He really doesn't have a lot of light
  • 31:23exposure and so you can see that that
  • 31:26yellow line here has very low amplitude
  • 31:27to it and if you talk to him about this,
  • 31:30he really prefers to spend
  • 31:32his time in dimly lit rooms.
  • 31:34He finds bright light,
  • 31:36kind of irritating and just
  • 31:38really doesn't like it.
  • 31:40So he fits the criteria for non 24
  • 31:42hour sleep break rhythm disorder
  • 31:43and if I didn't mention this before,
  • 31:45he does have normal image forming vision.
  • 31:47So this is not a blind patient.
  • 31:51So for non 24 they can come in
  • 31:53with lots of different complaints.
  • 31:55They can either have insomnia,
  • 31:57excessive daytime sleepiness or maybe
  • 31:59both depending on where you hit them
  • 32:01within that constant delay and cycle.
  • 32:03Some of them have figured out
  • 32:04what's going on,
  • 32:05but it's something to keep in mind
  • 32:06if you have somebody who just cannot
  • 32:08describe their sleep wake schedule to you.
  • 32:10Investigating a little bit
  • 32:11further with that trigger.
  • 32:13Fear sleep logs to really get a sense of
  • 32:16what the pattern is can be very helpful.
  • 32:19In terms of what causes this,
  • 32:20so this was first described
  • 32:22in blind individuals.
  • 32:23We're going to get into this
  • 32:25a little bit more later,
  • 32:26but really it makes sense if
  • 32:28you lose that photic input.
  • 32:30If you lose that light signal to the SDN,
  • 32:32telling the SDN when it's
  • 32:34night and when it's daytime,
  • 32:36you're then going to follow that
  • 32:38intrinsic rhythm and get later and
  • 32:39later and so in blind individuals.
  • 32:41This has been previously described,
  • 32:43although not everybody who's
  • 32:44blind has this disorder.
  • 32:45To keep that in mind.
  • 32:47And then in our patient here we do see
  • 32:49a lot of these in sighted patients.
  • 32:52It's likely multifactorial.
  • 32:53A combination of minimal social cues,
  • 32:56potentially a prolonged
  • 32:57intrinsic circadian period,
  • 32:59and what I most often see is that
  • 33:01these individuals will start as what
  • 33:03we call sort of the extreme delayed,
  • 33:06and then eventually they just sort
  • 33:07of fall off and become non 24,
  • 33:09and they may alternate and go back
  • 33:12and forth between the semi stable
  • 33:14and trainment and being non 24.
  • 33:17So going through the task force
  • 33:19guidelines on basically there
  • 33:20is a recommendation for the use
  • 33:22of timed melatonin.
  • 33:23Clinically, what we tend to do in blind,
  • 33:26we'll still follow that,
  • 33:27so typically using half a
  • 33:29milligram to 3 milligrams,
  • 33:31taking an hour before desired bedtime,
  • 33:33they're also is the approved
  • 33:35medication tasimelteon,
  • 33:36which we'll talk about in the next slide.
  • 33:39In sighted individuals,
  • 33:39it tends to get a little more complicated,
  • 33:42and so we have a number of
  • 33:45different protocols we've
  • 33:46been trying. We will often do half a
  • 33:49milligram of melatonin, about five
  • 33:52hours before their desired bedtime,
  • 33:54as more of the phase shifting dose,
  • 33:57and then an additional 1 milligram of
  • 33:59melatonin an hour before their desired
  • 34:00bedtime is more of a hypnotic dose.
  • 34:02Once they're close to their desired
  • 34:04bedtime to try to anchor them there,
  • 34:07we'll use very strict sleep schedules,
  • 34:09timed light exposure when they wake up,
  • 34:11and then we'll talk a little bit more
  • 34:13about some of these other things we've
  • 34:15used feeding and activity as well.
  • 34:17Just to go through has a meltdown,
  • 34:19so this is a melatonin agonist.
  • 34:21This is the data from the set and reset
  • 34:24trial indicating its effectiveness,
  • 34:26and in this trial they were just
  • 34:28looking at blind individuals and they
  • 34:30found that 20% of the patients in the
  • 34:32tasimelteon group met their criteria
  • 34:34for in treatment at one month compared
  • 34:36to only 3% in the placebo group.
  • 34:38So this is approved.
  • 34:40Technically,
  • 34:40the FDA indications do not specify
  • 34:43that you have to be blind or sighted,
  • 34:46just that you're not.
  • 34:4724 although sometimes you will
  • 34:49run into issues with insurance,
  • 34:51trying to say that oh, they're not blind,
  • 34:52we're not gonna cover this.
  • 34:53Usually that can be addressed
  • 34:55in a peer to peer.
  • 34:56The main reason I don't use this more though,
  • 34:58is that if you look down here,
  • 35:00the price of one month supply of
  • 35:03tasimelteon is about $23,000 compared to
  • 35:06$3.00 for one month supply of melatonin.
  • 35:09I don't have anything personally
  • 35:11against hazing Melton.
  • 35:12I think I've gotten a reputation
  • 35:13as somebody who doesn't like it.
  • 35:14It does work.
  • 35:15I just like to try the cheaper option.
  • 35:171st and then move to tasimelteon.
  • 35:19If I can't reach success with melatonin.
  • 35:23So we started treating that individual
  • 35:25and he got back to me after we got his
  • 35:29sleep wake schedule on track and he said,
  • 35:31well.
  • 35:31I'm going to bed and waking
  • 35:33up when I want to,
  • 35:34but now it really feels like my
  • 35:36body has three different schedules.
  • 35:37My physical self now seems to
  • 35:39follow a more normal schedule.
  • 35:41My mental self seems to be highly
  • 35:43nocturnal and my metabolism has
  • 35:45changed to require only one small meal
  • 35:47every 24 hours instead of 12 hours.
  • 35:49And for me this was really
  • 35:52interesting because this to me
  • 35:54said we have desynchronized him,
  • 35:57so I mentioned that we have clocks
  • 35:59throughout our all throughout our body
  • 36:01and it seemed like we had gotten.
  • 36:03Sleep wake schedule on track.
  • 36:05But for example, his peripheral clocks.
  • 36:08His metabolism was not in line with that,
  • 36:11so we got some sleep or some food
  • 36:13logs from him and you can see just
  • 36:15listed here his meals and I did some
  • 36:18estimated calories and it really
  • 36:19like you said he's just eating
  • 36:22one meal encompassing most of his
  • 36:24calories for the day at one time.
  • 36:26And so we started to do some additional
  • 36:29work with him on adjusting food timing.
  • 36:31Really coming up with the skeleton.
  • 36:33Eating period to be in alignment with his
  • 36:36sleep wake timing and we managed to get
  • 36:38him in trained and so now here he is.
  • 36:41He's still diligently and if this is now
  • 36:4310 years later I think almost he continues
  • 36:45to send me these monthly sleep Diaries
  • 36:47just to show me he's still on track.
  • 36:50He's still in trained.
  • 36:51We were able to get him back to work.
  • 36:53He's on a flexible schedule now so he
  • 36:55works more of like a second shift hour,
  • 36:57but he's going to work everyday and
  • 37:00is pretty happy with the schedule.
  • 37:02So that leads to the final question,
  • 37:04which is why do patients develop
  • 37:06delayed sleep, wake phase disorder,
  • 37:08and more importantly,
  • 37:09why do sighted patients develop
  • 37:12non 24 and we think about this
  • 37:15first in terms of light exposure.
  • 37:17So if we go back to that idea
  • 37:19of in treatment,
  • 37:20so how do the rest of us without
  • 37:24circulating disorders sleep when it's
  • 37:26dark and be awake during the daytime?
  • 37:28And we think a lot of that comes from
  • 37:30that daily exposure to sunshine.
  • 37:32Giving us that morning advancing
  • 37:34signal to keep us in line so that
  • 37:37we're asleep when it's dark.
  • 37:38So one theory for delayed sleep,
  • 37:40wake phase disorders.
  • 37:41Oh these are people who are just
  • 37:43staying up later and waking up later,
  • 37:45so maybe they're getting too much
  • 37:46light at night and it's pushing
  • 37:48them even later and they're getting
  • 37:49less of that morning.
  • 37:50Advancing signal because they're
  • 37:52just not waking up in time.
  • 37:54So we did one study trying to look at that,
  • 37:56and there are several of these
  • 37:57out there published,
  • 37:58and certainly if you look on the
  • 38:00left hand panel here at light
  • 38:03exposure related to clock time,
  • 38:05our delayed patients are here in blue
  • 38:07and you can see that midnight is over
  • 38:09here on the left and really anywhere
  • 38:11from about 10:00 PM to about 4:00 AM.
  • 38:13They're definitely getting more
  • 38:15light exposure than our controls,
  • 38:16getting much less light first thing
  • 38:18in the morning up until about noon.
  • 38:21But interestingly,
  • 38:21if you align that based on their.
  • 38:24Clock time so their internal time,
  • 38:26so using dim light melatonin onset
  • 38:29you can see that actually on this end.
  • 38:33So in that region of fades delay
  • 38:35there's really no difference in
  • 38:38that first early morning region.
  • 38:40There's really no difference.
  • 38:41We're only seeing a bit of a
  • 38:44difference in what we're terming
  • 38:45the late phase advance window,
  • 38:47so sort of later in the morning.
  • 38:50The delayed are getting a little
  • 38:52bit less light exposure than the.
  • 38:54Controls are getting,
  • 38:55and so we think they may be missing
  • 38:57out on a little bit of that phase.
  • 38:59Advancing signal,
  • 39:00but maybe not necessarily enough
  • 39:02to fully explain the phenotype
  • 39:05that we're seeing.
  • 39:06And So what are some other theories?
  • 39:08So,
  • 39:09another idea is that you get
  • 39:11the same light exposure,
  • 39:13but you have more of a response to it,
  • 39:15so maybe you're overly sensitive
  • 39:17to evening light or under
  • 39:19sensitive to morning light.
  • 39:21Sean Kane's group in Australia has done
  • 39:24some work looking at this and they did
  • 39:27find that with the exact same light
  • 39:29pulse patients who were delayed had a
  • 39:32larger phase delay and I don't like
  • 39:34how this graph is because the delay is
  • 39:37actually positive instead of negative,
  • 39:39but they have a larger fades delay as
  • 39:42well as greater suppression of melatonin
  • 39:44in response to an evening light pulse.
  • 39:47So there does seem to be some excess
  • 39:49sensitivity in some of these individuals.
  • 39:51But then what?
  • 39:52About the other question,
  • 39:53what about this morning light sensitivity?
  • 39:57So getting back to what I was touching
  • 39:59on before our eyes do a lot of things.
  • 40:02We have what we most commonly
  • 40:04think about this image,
  • 40:05forming visions that we look at an apple.
  • 40:07We see an apple,
  • 40:08but there's also non image forming vision.
  • 40:11So these are things like these
  • 40:13circadian light response.
  • 40:15The alerting effects of light
  • 40:16and that sort of thing.
  • 40:17So the image forming vision.
  • 40:19This is a an image of the retina
  • 40:21here image forming visions mediated
  • 40:23primarily by our rods and cones here.
  • 40:27That non image forming vision
  • 40:29is primarily mediated by these
  • 40:30intrinsically photosensitive retinal
  • 40:32ganglion cells that contain a
  • 40:35photo pigment called melanopsin,
  • 40:36and the nice thing about these
  • 40:39cells is that they not only project
  • 40:41to the SCN where they can mediate
  • 40:44the circadian signal of light,
  • 40:47but there's also a projection from
  • 40:49these cells into the brainstem to
  • 40:52the olivary pretectal nucleus,
  • 40:54which goes to the Edinger Westphal
  • 40:56nucleus which controls pupil.
  • 40:57Diameter so we can use that pathway
  • 40:59as a way of measuring how well
  • 41:02these cells are functioning.
  • 41:04We can do that in the clinic using
  • 41:06something called a pupillometer
  • 41:08as we have pictured here,
  • 41:09so there's a set of binoculars that
  • 41:11the subject is going to look into,
  • 41:13and then there's an infrared camera
  • 41:15that actually outlines the pupil
  • 41:17diameter as seen here and then you can
  • 41:20provide different light stimuli and
  • 41:22then measure the pupil response to light.
  • 41:25When we're looking at melanopsin,
  • 41:27these cells really give you a sense of
  • 41:30the overall light tone of the environment,
  • 41:34and so rather than being a second by
  • 41:36second response to the light that's there,
  • 41:39they hold sort of a static response,
  • 41:41and this is illustrated here.
  • 41:43If you look at the dotted blue line,
  • 41:44so we've got pupil diameter here.
  • 41:47If you provide a blue light stimulus,
  • 41:49the people constrict.
  • 41:50You turn off the stimulus,
  • 41:52and if those melanopsin cells are
  • 41:54functioning the way they're supposed to.
  • 41:56That pupil will read dilate but not
  • 41:59fully back to the baseline right away.
  • 42:02Compare that to somebody who doesn't
  • 42:04have well functioning melanopsin cells.
  • 42:07You can see the pupil diameter
  • 42:09here in the solid blue line,
  • 42:11they constrict,
  • 42:11and then they radiate essentially
  • 42:13back to where they were before,
  • 42:16and so we can use a measurement
  • 42:18called the PIPR,
  • 42:19which is literally just that
  • 42:21difference between the post
  • 42:22stimulation and the pre stimulation.
  • 42:24So the larger that is.
  • 42:26The better the melanopsin cells
  • 42:28are functioning, the smaller it is,
  • 42:30the worse they're functioning.
  • 42:32So our simple question was,
  • 42:34is the PIR impaired in patients with
  • 42:36delayed sleep wake phase disorder
  • 42:38non 24 and part of this comes back
  • 42:40to I mentioned before that patient
  • 42:42with non 24 had minimal light
  • 42:44exposure that tends to be a common
  • 42:47phenotype with these individuals
  • 42:48they tend to not like bright light.
  • 42:50They've kind of like your migraine
  • 42:52or they've turned down the
  • 42:53lights in the clinic room.
  • 42:54If they have the option to they
  • 42:56tend to spend more time in dimly
  • 42:59lit environments because the
  • 43:00light is irritating to them.
  • 43:02So these are our study participants.
  • 43:04We broke this down so we have our
  • 43:07control individuals here and then
  • 43:08within our clinical population
  • 43:09we had patients who came in
  • 43:11with purely delayed sleep,
  • 43:12wake phase disorder,
  • 43:13and I say that they just had a
  • 43:16problem based on ICSD 3 criteria that
  • 43:18they're sleep like timing was late,
  • 43:20but they never had a time period
  • 43:21where it actually got later and
  • 43:23later and went around the clock.
  • 43:24We had twelve of those and then we had 12
  • 43:27patients who had symptoms of delayed sleep,
  • 43:30wake phase disorder.
  • 43:31But if you asked them that.
  • 43:32Question,
  • 43:33have you ever actually gotten so late
  • 43:34that you've gone around the clock?
  • 43:36Do you go back and forth
  • 43:37between those two states?
  • 43:38We had 17 patients who had that phenotype.
  • 43:42Overall, similar age.
  • 43:43Obviously lower scores on the
  • 43:46Horn osberg indicating more
  • 43:48eveningness within this population.
  • 43:51Worst scores on PSQI,
  • 43:52which is previously been
  • 43:54described in DSPD patients,
  • 43:56but not any sleepier than our controls,
  • 43:59and then the average sleep onset,
  • 44:01offset and sleep midpoint,
  • 44:02was significantly later in our delayed and
  • 44:05even later in our non 24 overlap group,
  • 44:08but total sleep time was the same
  • 44:10across all groups and then lastly
  • 44:12the people on the tree testing in
  • 44:15relation to time since they woke up
  • 44:18was slightly closer to wake time.
  • 44:21And our delayed and non 24
  • 44:23overlap compared to our controls.
  • 44:25But we know that from previously
  • 44:27published studies the PIPR only tends
  • 44:29to change around the time of dim light,
  • 44:32melatonin onset and otherwise remains
  • 44:33fairly stable throughout the day,
  • 44:35and so we were well away from the Duomo
  • 44:38window for all of these individuals.
  • 44:41This is data from one control
  • 44:43and one delayed subject.
  • 44:44Just showing an example of the tracing.
  • 44:47And as you can see here,
  • 44:49our delayed patient in the solid blue,
  • 44:53there's their pupil diameter.
  • 44:54You provide the light stimulus,
  • 44:56the pupil constricts.
  • 44:57They radiate almost to exactly
  • 44:59where they were pre stimulus
  • 45:01compared to our control,
  • 45:03who constricts and then maintains
  • 45:05that constriction post stimulus so you
  • 45:09can see smaller pipr in our delayed
  • 45:12patient compared to our control.
  • 45:14This is just quantifying it here
  • 45:16and so you can see controls.
  • 45:18Overall have a larger Pi PR
  • 45:21significantly greater than the
  • 45:23non 24 hour overlap,
  • 45:24and then there's kind of a range within
  • 45:27that just delayed group which we think
  • 45:29may come from the fact that there
  • 45:31are several different phenotypes of delayed.
  • 45:33There's sort of this.
  • 45:35We're still working on terminology,
  • 45:36but some of them have a mismatch between
  • 45:38their demo timing and their preferred timing,
  • 45:41and some of them are both their
  • 45:42demo and their sleep wake.
  • 45:44I mean it's delayed,
  • 45:45so I think that we're capturing that with
  • 45:47some of the variability that we see here.
  • 45:49But essentially this is a first pass,
  • 45:51telling us that we think that we
  • 45:53may have found a subpopulation
  • 45:55of individuals who have at least
  • 45:58based on bedside and office exam,
  • 46:00have normal image forming vision,
  • 46:02but they're non image forming.
  • 46:04Vision may have some impairment and
  • 46:06this may be part of why they end up
  • 46:09either delayed or developing this non
  • 46:1124 hour phenotype because they're just
  • 46:13simply not able to respond normally to
  • 46:16that morning advancing light signal.
  • 46:19And so with that,
  • 46:20I'd just like to acknowledge the people
  • 46:21who helped me out with this project
  • 46:23and elsewhere within the clinic.
  • 46:24Uh, the funding sources for this,
  • 46:26as well as their clinical staff
  • 46:27who conducted some of the people
  • 46:29on the tree measures and have been
  • 46:31phenomenal at helping to manage
  • 46:32these circadian patients as well.
  • 46:34And with that,
  • 46:34I believe I did allow some
  • 46:36extra time for questions.
  • 46:41Fantastic thank you.
  • 46:43Thank you very much Sabra.
  • 46:46A great great journey from the basics to
  • 46:49clinic and over to the field of research.
  • 46:52And so the question the the
  • 46:55pupil is a amazing thing.
  • 46:59And So what happens to the people
  • 47:02and people who may not have sort of?
  • 47:08May not be healthy otherwise,
  • 47:09so like it is our comorbidities
  • 47:12such as you know, diabetes,
  • 47:14hypertension, etcetera.
  • 47:15Obesity, for example,
  • 47:16affect people that are responses.
  • 47:20Absolutely. And So what I left out in
  • 47:22the abbreviated summary is that we took
  • 47:25very otherwise healthy individuals,
  • 47:27and so the pupil does so many
  • 47:30different things. It gives you an
  • 47:32insight into autonomic function,
  • 47:34and so that's often where we
  • 47:35tend to use pupillometry,
  • 47:36particularly in the ICU,
  • 47:37in the diabetes realm.
  • 47:39And so it can give you a sense of
  • 47:41parasympathetic sympathetic balance that
  • 47:43tends to be that more immediate response.
  • 47:46And we do see some differences in these
  • 47:48patients in that autonomic realm.
  • 47:50As well, and then the PIPR that we were
  • 47:54looking at tends to do more of that
  • 47:56retinal ganglion cell measurement,
  • 47:58but you can see a loss of those
  • 47:59and lots of other disorders besides
  • 48:02delayed supplicates disorders,
  • 48:03so it's been reported there's been
  • 48:05impairment in seasonal affective disorder.
  • 48:07We think that there may be some drop
  • 48:09out of this in patients with Parkinson's,
  • 48:10and so absolutely,
  • 48:12I think you just examining the
  • 48:14people alone could find you know
  • 48:16problems in almost every disorder.
  • 48:20Cool well if you into the soul all right.
  • 48:25All right, so so we have some other
  • 48:26questions and I have a couple more,
  • 48:28but I want to make sure I address
  • 48:29the the folks in the Chancellor.
  • 48:31Doctor Cohen is asking does
  • 48:32the use of chronic exogenous
  • 48:34melatonin have any impact on ones
  • 48:38endogenous melatonin secretion?
  • 48:39So does it suppress it?
  • 48:42As we know, and certainly not
  • 48:44at the doses that we tend to
  • 48:46use for our circadian patients,
  • 48:47and so I will see a lot of patients
  • 48:50who show up in clinic, and I think
  • 48:52our typical response is always well.
  • 48:54If something doesn't work,
  • 48:55let me take more of it and so I think
  • 48:57the record I've seen is somebody who
  • 48:58came in by the time they came to see me.
  • 49:00They were taking 80 milligrams
  • 49:02of melatonin at night.
  • 49:03I was surprised that they were actually
  • 49:05still awake in time for their appointment,
  • 49:07but in those doses I might be
  • 49:11more concerned about this.
  • 49:12But using half a milligram,
  • 49:14just trying to mimic physiological doses.
  • 49:16We haven't noticed any.
  • 49:17Inability to produce your own melatonin.
  • 49:20Know sort of negative feedback loop.
  • 49:21Anything like that,
  • 49:23right? Cool? Yeah, because I think
  • 49:24you know a lot of people use
  • 49:27melatonin for induction of sleep,
  • 49:28and some of them go up,
  • 49:29you know, 1012 etcetera and so,
  • 49:32and so that that always that's the cross.
  • 49:35Our mind as we think about this.
  • 49:37And so, doctor Ahn says,
  • 49:39and have you found that there are any
  • 49:42dietary effects on melatonin testing?
  • 49:44So I have read that nuts,
  • 49:47fruits, alcohol?
  • 49:48Rice can increase melatonin levels,
  • 49:50and you instruct patients to avoid
  • 49:52these substances and the night when
  • 49:53they do their military and testing.
  • 49:55So we have a whole set of
  • 49:57instructions that we give patients,
  • 49:58so there's a bunch of things
  • 50:00that can affect melatonin.
  • 50:01I think one of the most important things
  • 50:03to keep in mind is beta blockers actually
  • 50:06inhibit melatonin production, so.
  • 50:10Keeping that in mind when you're
  • 50:11testing your patients bananas,
  • 50:13ibuprofen other things can also influence it,
  • 50:17and so we in general instruct
  • 50:19patients do as much as possible,
  • 50:21don't eat anything within 15 minutes
  • 50:24of doing the saliva testing as well.
  • 50:27But yeah, there's lots of things that
  • 50:30can influence melatonin production,
  • 50:31so we do try to instruct subjects
  • 50:33to be careful with them.
  • 50:37So from a practical standpoint.
  • 50:41How do you order the milestone testing?
  • 50:44Who passed for it? Is that a pocket?
  • 50:46Because I I want to do it with
  • 50:48my patience and so how do I?
  • 50:49How do I? How do I do that?
  • 50:51I mean, I've done it before,
  • 50:52but it was, you know,
  • 50:54it took a little legwork
  • 50:55right now. Our kids are homegrown,
  • 50:58so we put them together ourselves and
  • 50:59had to go through a whole process of
  • 51:01making our own epic order and everything
  • 51:03else to be able to implement and
  • 51:05them implement them in the clinic.
  • 51:09There is at least one commercial testing
  • 51:11group available that I've seen out there.
  • 51:13Their prices tended to be a little bit higher
  • 51:16and I would interpret the data yourself.
  • 51:21But the right now I think the biggest
  • 51:25downside to melatonin testing is
  • 51:27it's not covered by insurance.
  • 51:30We are working as a sort of consortium
  • 51:32of people interested in circulating
  • 51:34disorders on putting out a paper on
  • 51:36melatonin testing and sort of the
  • 51:38clinical benefits of it and continuing
  • 51:40to work to try to get insurance
  • 51:42companies to routinely reimburse
  • 51:43for both demo testing and you didn't
  • 51:46open the other can of worms,
  • 51:47which is getting reimbursed
  • 51:48for actigraphy testing,
  • 51:50which we're also working on.
  • 51:52Well, thank you and I'm
  • 51:54doing it on both sides.
  • 51:55That doctor Hilbert has a question.
  • 51:57Given the variability and over
  • 51:59the counter melatonin branch of
  • 52:01brand or locked a lot even what
  • 52:03do you recommend from melatonin
  • 52:06prescription or or purchases?
  • 52:08It has to be USB grade or.
  • 52:11So I I wear two hats on this.
  • 52:14UM, my clinical hat is really what I care
  • 52:17about more is that they get a low dose
  • 52:19and whatever they're able to track down,
  • 52:22as long as it's half a milligram.
  • 52:24I'm actually fine with that.
  • 52:25We do have some specific melatonin that
  • 52:28we use for research studies and tend to be
  • 52:31a little bit more consistent with that,
  • 52:33but it's you know it's the
  • 52:36practicalities and medicine of trying
  • 52:38to get patients what they need.
  • 52:40One of my odd.
  • 52:41Of odd hobbies Prepandemic was I
  • 52:43would wander around drug stores in
  • 52:45the area and start looking at their
  • 52:47melatonin Isles and I would sort of
  • 52:49keep my running list of where within
  • 52:51walking area of the hospital you could
  • 52:53actually find low dose melatonin so
  • 52:54I could direct patients there too.
  • 52:57Nice OK great. And and
  • 53:01so I I think so. So the.
  • 53:06I guess one of the other questions I had was.
  • 53:12Do you use any other technology other than?
  • 53:16Actigraphy is there anything else out
  • 53:19there that is close enough to actigraphy to
  • 53:23be used to understand activity patterns?
  • 53:27So, are you referring to things like like a
  • 53:30wearable personal wearables? Yeah,
  • 53:32I will take whatever data I can get
  • 53:34and I don't want to mess up my camera,
  • 53:37but the bulletin board that I have
  • 53:39right behind me in my office here
  • 53:42actually has examples of many different
  • 53:44types of sleep logs and reportable
  • 53:47data that I've gotten from patients.
  • 53:49Like I said, they tend to track
  • 53:52their data before they come in,
  • 53:54and so if all you have access to
  • 53:55and I think we also got much more.
  • 53:58Creative with this in the pandemic
  • 53:59when we had times where we couldn't
  • 54:01send out actigraphy,
  • 54:02we couldn't get all the data on
  • 54:04the way that we normally did.
  • 54:06If they wanna send me Fitbit data with
  • 54:08all the caveats of how accurate that is,
  • 54:11whatever data they have available
  • 54:12and can send me, that's great.
  • 54:14The downside to those,
  • 54:16and where I can get some insight
  • 54:18with that tiger fee that I can't
  • 54:20get from some of the consumer
  • 54:21wearables is light exposure data and
  • 54:23that is a tool that we often use,
  • 54:25and so we'll often find,
  • 54:27for example, in these delayed.
  • 54:28Since we can get a sense of ohh
  • 54:30you actually get a ton of light
  • 54:31right before bedtime or you have
  • 54:33horrible curtains in your bedroom
  • 54:34and you're getting a bunch of morning
  • 54:36light before you're waking up.
  • 54:37And so that's some insight that I can't
  • 54:39necessarily get from the consumer wearables.
  • 54:42But if we're just getting a
  • 54:43sense of overall patterns,
  • 54:45we're trying to get a sense
  • 54:46of treatment response.
  • 54:47They're great and we've been trying to
  • 54:49find ways to more easily get that data.
  • 54:52Like not knowing the ends when
  • 54:54you need to know the house, right?
  • 54:57You gotta have both sides of the equation.
  • 54:59OK wonderful, so so Sabra.
  • 55:01This is really great and so if you
  • 55:04were to give you know two bullets
  • 55:07of advice for somebody who is
  • 55:10managing a delayed phase patient,
  • 55:13what would be the one thing you have to do?
  • 55:15And one thing you should never do.
  • 55:18Never give light at 8:00 AM unless that's
  • 55:22their natural wake time and you have
  • 55:25to. Why is that? Why don't you give let Adam
  • 55:27why don't you give light at 8:00 AM?
  • 55:28Because at that point you're
  • 55:30probably gonna end up delaying
  • 55:31them and making them even worse
  • 55:33instead of making them better.
  • 55:35And the one thing you should do
  • 55:37is keep that melatonin dose low.
  • 55:39So like I said, typically half
  • 55:41a milligram no more than half a
  • 55:43milligram to 3 milligrams don't
  • 55:45get up into ten 2080 milligrams,
  • 55:48OK? Perfect excellent,
  • 55:49so early and low and then late
  • 55:53and bright I guess is the.
  • 55:57Cool awesome well great.
  • 55:58Thank you very much.
  • 56:00And so if anybody else has any other
  • 56:02questions we could probably well.
  • 56:04Actually, it's 259 so we're we're just
  • 56:06out of time and so thank you so much, Sabra.
  • 56:08This was wonderful and thank
  • 56:10you everyone for attending yet
  • 56:11another edition of our conference.
  • 56:13Please if you wanted to have your
  • 56:15credit for attending this conference,
  • 56:17you can go ahead and use the CME
  • 56:20code and we will see you guys in
  • 56:22May in the second Wednesday of May.
  • 56:24Thank you so much everybody.
  • 56:28My favorite.
  • 56:30For having me.